what's better compounded semaglutide or tirzepatide vs. Tirzepatide: the Difference and Which Is Right for You?: Envizion Medical: Wellness Center Tirzepatide vs. Semaglutide: Which is

10 It also inactivates GLP-1 (and the other human incretin GIP) rapidly and thus activity of GLP-1 in non-augmented physiology is relatively short lived ( 70% had existing cardiovascular disease (CVD) (EXSCEL)

Bohacek J, Mansuy IM

GLP-1 receptor agonists are medicines prescribed for type 2 diabetes and, in some cases, obesity 2

Multiple preclinical studies have investigated BPC-157 in crush injury and transection muscle models, examining myocyte repair kinetics, satellite cell activity, and functional recovery metrics in controlled laboratory settings

Figure 1: FDA Approved Incretin Mimetic (GLP-1 and dual agonist) Diabetes and Obesity Products (as of December 2023) The Future of Incretin Mimetics in Diabetes and Obesity Looking Forward GLP-1 Clinical Development Pipeline Looking Forward GLP-1 Clinical Development Pipeline While Novo Nordisk and Eli Lilly dominate todays market, the success of incretin mimetics has attracted greater interest and investment, with a slew of potential new players aiming to enter and carve out their own space

In my practice I use both specific remedies and combination remedies depending on the conditions being treated and the availability of remedies